Stinchcombe TE - Search Results

1

KRAS mutation: should we test for it, and does it matter?

Roberts PJ, Stinchcombe TE. Roberts PJ, et al. Among authors: stinchcombe te. J Clin Oncol. 2013 Mar 10;31(8):1112-21. doi: 10.1200/JCO.2012.43.0454. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401440 Review.

2

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.

Orlowski RZ, Stinchcombe TE, Mitchell BS, Shea TC, Baldwin AS, Stahl S, Adams J, Esseltine DL, Elliott PJ, Pien CS, Guerciolini R, Anderson JK, Depcik-Smith ND, Bhagat R, Lehman MJ, Novick SC, O'Connor OA, Soignet SL. Orlowski RZ, et al. Among authors: stinchcombe te. J Clin Oncol. 2002 Nov 15;20(22):4420-7. doi: 10.1200/JCO.2002.01.133. J Clin Oncol. 2002. PMID: 12431963 Clinical Trial.

3

Drug development in patients with advanced non-small cell lung cancer and poor performance status.

Stinchcombe TE, Socinski MA. Stinchcombe TE, et al. Semin Oncol. 2004 Dec;31(6 Suppl 11):21-6. doi: 10.1053/j.seminoncol.2004.10.005. Semin Oncol. 2004. PMID: 15599831 Review.

4

Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status.

Stinchcombe TE, Choi J, Schell MJ, Mears A, Jones PE, Nachtsheim RV, Socinski MA. Stinchcombe TE, et al. Lung Cancer. 2006 Feb;51(2):237-43. doi: 10.1016/j.lungcan.2005.10.018. Epub 2005 Dec 27. Lung Cancer. 2006. PMID: 16378657 Clinical Trial.

5

Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.

Stinchcombe TE, Lee CB, Socinski MA. Stinchcombe TE, et al. Clin Lung Cancer. 2006 May;7 Suppl 4:S111-7. doi: 10.3816/clc.2006.s.002. Clin Lung Cancer. 2006. PMID: 16764751 Review.

6

Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.

Stinchcombe TE, Socinski MA, Gangarosa LM, Khandani AH. Stinchcombe TE, et al. J Clin Oncol. 2006 Oct 20;24(30):4939-40. doi: 10.1200/JCO.2006.06.3354. J Clin Oncol. 2006. PMID: 17050879 No abstract available.

7

Radiation-induced sarcoma after high-dose thoracic radiation therapy in non-small-cell lung cancer.

Stinchcombe TE, Walters R, Khandani AH, Socinski MA. Stinchcombe TE, et al. J Clin Oncol. 2007 Apr 20;25(12):1621-3. doi: 10.1200/JCO.2006.10.3267. J Clin Oncol. 2007. PMID: 17443003 No abstract available.

8

Bevacizumab in the treatment of non-small-cell lung cancer.

Stinchcombe TE, Socinski MA. Stinchcombe TE, et al. Oncogene. 2007 May 28;26(25):3691-8. doi: 10.1038/sj.onc.1210366. Oncogene. 2007. PMID: 17530022 Review.

9

High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history.

O'Neil BH, Allen R, Spigel DR, Stinchcombe TE, Moore DT, Berlin JD, Goldberg RM. O'Neil BH, et al. Among authors: stinchcombe te. J Clin Oncol. 2007 Aug 20;25(24):3644-8. doi: 10.1200/JCO.2007.11.7812. J Clin Oncol. 2007. PMID: 17704414

10

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.

Stinchcombe TE, Harper HD, Hensing TA, Moore DT, Crane JM, Atkins JN, Willard EM, Detterbeck FC, Socinski MA. Stinchcombe TE, et al. J Thorac Oncol. 2008 Feb;3(2):145-51. doi: 10.1097/JTO.0b013e318160c5f1. J Thorac Oncol. 2008. PMID: 18303435 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page